0.00%
5.13%
6.13%
4.42%
49.52%
-13.73%
11.29%
AI Spotlight on CCEL
Company Description
Cryo-Cell International, Inc.engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use.It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases.
The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells.It stores approximately 500,000 cord blood and cord tissue stem cells worldwide.The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Cryo-Cell International, Inc.was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Market Data
| Last Price | 7.79 |
| Change Percentage | 0.00% |
| Open | 7.94 |
| Previous Close | 7.79 |
| Market Cap ( Millions) | 63 |
| Volume | 9648 |
| Year High | 9.5 |
| Year Low | 4.47 |
| M A 50 | 7.94 |
| M A 200 | 7.56 |
Financial Ratios
| FCF Yield | 2.79% |
| Dividend Yield | 3.21% |
| ROE | 85.69% |
| Debt / Equity | -122.72% |
| Net Debt / EBIDTA | -125.03% |
| Price To Book | -6.57 |
| Price Earnings Ratio | -7.04 |
| Price To FCF | 35.79 |
| Price To sales | 1.97 |
| EV / EBITDA | -8.06 |
News
- Jan -29 - Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
- Apr -15 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
- Oct -12 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results
- Jul -14 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results
- Apr -21 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results
- Feb -11 - Cryo-Cell International: A Stable Business Paired With An Upcoming Catalyst
- Oct -15 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
- Sep -20 - Cryo-Cell International Announces Changes To Its Board of Directors
- Aug -30 - Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
- Aug -20 - Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
- Aug -11 - Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021
- Jul -15 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results
- Jun -25 - Cryo-Cell International: Overlooked Duke Contract Signals Business Inflection
- Jul -19 - IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims against Cryo-Cell International, Inc. and Advises Investors to Contact the Firm
- Jun -30 - SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Cryo-Cell International, Inc. And Advises Investors With Losses to Contact the Firm
- May -18 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Violations of Delaware Law by Certain Officers and Directors of Cryo-Cell International, Inc.
- Aug -31 - Cryo-Cell Announces Results of 2011 Election of Board of Directors
- Aug -18 - CORRECTING and REPLACING Letter From Portnoy Group to Cryo-Cell Shareholders
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Umbilical Cord Blood and Cord Tissue Stem Cell Service
Expected Growth : 6 %
What the company do ?
Cryo-Cell International's Umbilical Cord Blood and Cord Tissue Stem Cell Service preserves stem cells from newborns' umbilical cords for potential future medical use.
Why we expect these perspectives ?
Increasing demand for regenerative medicine, growing awareness of stem cell therapy, rising private banking, and expanding research in cord blood and tissue applications drive growth in Cryo-Cell's umbilical cord blood and cord tissue stem cell service, with a growth rate of 6.
Segment n°2 -> Public Cord Blood Banking
Expected Growth : 5 %
What the company do ?
Public Cord Blood Banking from Cryo-Cell International, Inc. is a program that collects, processes, and stores umbilical cord blood units for public use, making them available for transplantation to anyone in need.
Why we expect these perspectives ?
Increasing demand for stem cell therapies, growing awareness of cord blood banking, expanding insurance coverage, and strategic partnerships drive growth in public cord blood banking. Cryo-Cell International, Inc.'s leadership in the market, coupled with its innovative storage methods and expanding global presence, contribute to its 5% growth rate.
Segment n°3 -> PrepaCyte Cord Blood
Expected Growth : 7 %
What the company do ?
PrepaCyte-CB is a cord blood processing system from Cryo-Cell International, Inc. that preserves stem cells for potential future medical use.
Why we expect these perspectives ?
Strong demand for cord blood stem cells in regenerative medicine, increasing awareness of newborn stem cell preservation, and Cryo-Cell's market leadership position drive 7% growth in PrepaCyte Cord Blood sales. Expanding healthcare applications, strategic partnerships, and investments in R&D further fuel growth.
Cryo-Cell International, Inc. Products
| Product Range | What is it ? |
|---|---|
| Cord Blood Banking | Cryo-Cell International, Inc. offers cord blood banking services, which involves collecting and storing umbilical cord blood stem cells for potential future medical use. |
| Cord Tissue Banking | The company also offers cord tissue banking, which involves collecting and storing umbilical cord tissue for potential future use in regenerative medicine. |
| Dental Stem Cell Banking | Cryo-Cell International, Inc. provides dental stem cell banking services, which involves collecting and storing dental pulp stem cells from teeth. |
| Adipose Tissue Banking | The company offers adipose tissue banking, which involves collecting and storing adipose-derived stem cells from fat tissue. |
Cryo-Cell International, Inc.'s Porter Forces
Threat Of Substitutes
Cryo-Cell International, Inc. operates in a niche market with limited substitutes, but the threat of substitutes is still present due to the emergence of new technologies and competitors.
Bargaining Power Of Customers
Cryo-Cell International, Inc. has a diverse customer base, which reduces the bargaining power of individual customers. Additionally, the company's products and services are specialized, making it difficult for customers to switch to alternative providers.
Bargaining Power Of Suppliers
Cryo-Cell International, Inc. relies on a limited number of suppliers for its raw materials and equipment. While the company has some bargaining power due to its size and reputation, suppliers still have some leverage in negotiations.
Threat Of New Entrants
The cord blood banking industry has high barriers to entry, including significant capital expenditures and regulatory hurdles. This limits the threat of new entrants and allows Cryo-Cell International, Inc. to maintain its market position.
Intensity Of Rivalry
The cord blood banking industry is highly competitive, with several established players competing for market share. Cryo-Cell International, Inc. must continually innovate and differentiate itself to maintain its market position.
Capital Structure
| Value | |
|---|---|
| Debt Weight | -8059.07% |
| Debt Cost | 6.50% |
| Equity Weight | 8159.07% |
| Equity Cost | 6.50% |
| WACC | 6.50% |
| Leverage | -98.77% |
Cryo-Cell International, Inc. : Quality Control
Cryo-Cell International, Inc. passed 4 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| NHC | National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing … |
| AMS | American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat … |
| ASTH | Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. … |
| ADUS | Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United … |
| CCRN | Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Cryo-Cell International
A-Score
1-Year Total Return ->
🥈
NHC
A-Score
1-Year Total Return ->
🥉
Addus HomeCare
A-Score
1-Year Total Return ->
4
ASHS
A-Score
1-Year Total Return ->
5
Astrana Health
A-Score
1-Year Total Return ->
6
